A look at vaccine history, markets, manufacturing, and overcoming the scale-up dilemma.
Jose Castillo, PhD
Advertisement
Articles by Jose Castillo, PhD
Scaling up stem-cell cultures requires careful consideration of the bioreactor design.
Advertisement
Latest Updated Articles
The Vaccine SceneFebruary 1st 2013
Considerations for Scale-Up Stem-Cell CulturesNovember 1st 2012
Advertisement
Advertisement
Trending on BioPharm International
1
AstraZeneca Acquires Omniose, Adding Bioconjugate Vaccine Platform
2
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
3
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
4
The BioPharm Brief: FDA Designations for a Bispecific CAR-T, a BLA for Friedreich’s Ataxia, and Phase 2b MASH Data for Efinopegdutide
5